Insilico: Two Non-Executive Directors to Step Down Effective 15 July 2026

Bulletin Express

07/15

Insilico Medicine Cayman TopCo (Insilico) announced that Non-Executive Directors Dr. Kan Chen and Mr. Long Shi have tendered their resignations, effective 15 July 2026.

Dr. Chen, currently a member of the Board’s nomination committee, cited changes in work arrangements and other business commitments. Mr. Shi, a member of the remuneration committee, provided the same reason for his departure.

According to the filing, the resignations are not linked to Insilico’s business, operations, or financial performance. Both Directors confirmed they have no claim against the company, no disagreement with the Board, and no matters requiring shareholder attention.

The Board expressed appreciation for Dr. Chen’s and Mr. Shi’s contributions. As of the announcement date, the Board comprises: • Executive Directors: Dr. Aleksandrs Zavoronkovs (Chairman, CEO, CBO) and Dr. Feng Ren • Non-Executive Director: Dr. Chuen Yan Leung • Independent Non-Executive Directors: Dr. Jingsong Wang, Dr. Denitsa Milanova and Mr. Roman Kyrychynskyi

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hant/news/1181859973"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1181859973\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1181859973?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-15 22:21","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1181859973","market":"hk","top_or_hot":-1,"title":"Insilico: Two Non-Executive Directors to Step Down Effective 15 July 2026","media":"Bulletin Express","content":"<p>Insilico Medicine Cayman TopCo (Insilico) announced that Non-Executive Directors Dr. Kan Chen and Mr. Long Shi have tendered their resignations, effective 15 July 2026.</p>\n<p>Dr. Chen, currently a member of the Board’s nomination committee, cited changes in work arrangements and other business commitments. Mr. Shi, a member of the remuneration committee, provided the same reason for his departure.</p>\n<p>According to the filing, the resignations are not linked to Insilico’s business, operations, or financial performance. Both Directors confirmed they have no claim against the company, no disagreement with the Board, and no matters requiring shareholder attention.</p>\n<p>The Board expressed appreciation for Dr. Chen’s and Mr. Shi’s contributions. As of the announcement date, the Board comprises:  \n• Executive Directors: Dr. Aleksandrs Zavoronkovs (Chairman, CEO, CBO) and Dr. Feng Ren  \n• Non-Executive Director: Dr. Chuen Yan Leung  \n• Independent Non-Executive Directors: Dr. Jingsong Wang, Dr. Denitsa Milanova and Mr. Roman Kyrychynskyi</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Insilico: Two Non-Executive Directors to Step Down Effective 15 July 2026</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nInsilico: Two Non-Executive Directors to Step Down Effective 15 July 2026\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time smaller\">2026-07-15 22:21</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Insilico Medicine Cayman TopCo (Insilico) announced that Non-Executive Directors Dr. Kan Chen and Mr. Long Shi have tendered their resignations, effective 15 July 2026.</p>\n<p>Dr. Chen, currently a member of the Board’s nomination committee, cited changes in work arrangements and other business commitments. Mr. Shi, a member of the remuneration committee, provided the same reason for his departure.</p>\n<p>According to the filing, the resignations are not linked to Insilico’s business, operations, or financial performance. Both Directors confirmed they have no claim against the company, no disagreement with the Board, and no matters requiring shareholder attention.</p>\n<p>The Board expressed appreciation for Dr. Chen’s and Mr. Shi’s contributions. As of the announcement date, the Board comprises:  \n• Executive Directors: Dr. Aleksandrs Zavoronkovs (Chairman, CEO, CBO) and Dr. Feng Ren  \n• Non-Executive Director: Dr. Chuen Yan Leung  \n• Independent Non-Executive Directors: Dr. Jingsong Wang, Dr. Denitsa Milanova and Mr. Roman Kyrychynskyi</p>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"03696","symbol_name":"英矽智能","start_time":0,"source_url":"","article_id":"1181859973","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1181859973","pubTimestamp":1784125265,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Insilico Medicine Cayman TopCo (Insilico) announced that Non-Executive Directors Dr. Kan Chen and Mr. Long Shi have tendered their resignations, effective 15 July 2026. Dr. Chen, currently a member...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"03696":"英矽智能"},"translate_title":"Insilico：两名非执行董事将于 2026 年 7 月 15 日辞职","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"03696":1},"content_text":"Insilico Medicine Cayman TopCo (Insilico) announced that Non-Executive Directors Dr. Kan Chen and Mr. Long Shi have tendered their resignations, effective 15 July 2026.\nDr. Chen, currently a member of the Board’s nomination committee, cited changes in work arrangements and other business commitments. Mr. Shi, a member of the remuneration committee, provided the same reason for his departure.\nAccording to the filing, the resignations are not linked to Insilico’s business, operations, or financial performance. Both Directors confirmed they have no claim against the company, no disagreement with the Board, and no matters requiring shareholder attention.\nThe Board expressed appreciation for Dr. Chen’s and Mr. Shi’s contributions. As of the announcement date, the Board comprises:  \n• Executive Directors: Dr. Aleksandrs Zavoronkovs (Chairman, CEO, CBO) and Dr. Feng Ren  \n• Non-Executive Director: Dr. Chuen Yan Leung  \n• Independent Non-Executive Directors: Dr. Jingsong Wang, Dr. Denitsa Milanova and Mr. Roman Kyrychynskyi","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"executive,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}